DENVER – The COVID-19 vaccine has been shown to be an effective measure in preventing infections, serious illness, hospitalization and death in Colorado, according to new data released Wednesday by the Colorado Department of Public Health and Environment and now widely available for use. public.
The CDPHE on Wednesday launched a COVID-19 vaccine progress board that, for the first time, gives citizens a glimpse into the intensity of vaccines.
The online dashboard provides a snapshot of the advanced cases of COVID-19 reported in Colorado and compares this data with unvaccinated cases in the state.
The dashboard also provides demographic breakdowns and will be updated weekly for advanced cases and vaccinated hospitalizations. Vaccinated death data will be updated monthly.
How effective are vaccines?
For the week of August 22, there were 96.1 vaccinated cases per 100,000 people, with a mean age of 45. It compares with 327 unvaccinated cases per 100,000 people, with a mean age of 32 years.
CDPHE
And when it comes to hospitalizations and deaths, vaccines are even more effective at preventing those results, according to the data.
During the week of August 15, there were 3.5 vaccinated hospitalizations per 100,000 people, with an average age of 73 years. In July, the state recorded 8.1 vaccinated deaths per 100,000, with an average age of 79 years.
But those who are not vaccinated did worse. During the same week in August, there were 13.2 unvaccinated hospitalizations per 100,000 people, with an average age of 58. And for the month of July, 46.9 unvaccinated deaths per 100,000 people were recorded. with an average age of 76 years.
State epidemiologist Dr. Rachel Herlihy said Wednesday hospitalizations continue to rise in the state.
As of Wednesday, there were 891 people admitted to Colorado by COVID-19, the highest since January. He said most of the hospitalized are not vaccinated.
“Most of the transmission, most of the hospitalization actually occurs among our unvaccinated population,” Dr. Herlihy said.
He said the CDPHE is seeing a decline in vaccine efficacy as the delta variant emerges as the dominant strain, but the decline is not substantial.